Website Preloader
Our Insights

Our insights

Thought leadership, insight and news from Uniphar
"
"
The impact of EU pharmaceutical reform

The impact of EU pharmaceutical reform

Uniphar was delighted to welcome European industry leaders to Zurich to debate the proposed EU pharmaceutical legislation reform, and incoming HTA reform. The conversation was held against the backdrop of the EU elections, and discussions focused on the impact of both on the pharma industry globally.

Reform of EU Pharmaceutical Legislation – where do we stand?

Reform of EU Pharmaceutical Legislation – where do we stand?

Unlock valuable insights and download our informative report

Europe’s decisive role in global healthcare’s future 

Europe’s decisive role in global healthcare’s future 

As we look ahead to 2028, a confluence of factors will position Europe to play a decisive role in shaping the future of global healthcare. From policy leadership to research and development prowess, Europe's impact will be felt across many dimensions.

Realistic differentiation: Why unifying medical, early access, and commercial strategy is the only way forward in Europe 

Realistic differentiation: Why unifying medical, early access, and commercial strategy is the only way forward in Europe 

In today's healthcare landscape, biopharma is under immense pressure to differentiate every element of their products and services. With regulations continuously evolving and competition intensifying, traditional siloed approaches are no longer sufficient.

Go-to-Market Innovation in 2028: The essential disruption dimensions for thriving in the new European healthcare landscape

Go-to-Market Innovation in 2028: The essential disruption dimensions for thriving in the new European healthcare landscape

As we look ahead to 2028, the European healthcare market is poised for significant disruption.

Supporting the patient doctor relationship – five top tips 

Supporting the patient doctor relationship – five top tips 

Our last insight on this topic explored how patients have become more empowered as decision makers when it comes to their healthcare.

How the pharmacist has become a key decision maker  

How the pharmacist has become a key decision maker  

The role of the pharmacist in the pharma industry has evolved and their place in prescribing has accelerated. They are now key decision makers who need to be considered in pharma’s strategic approaches.

The rise of the patient decision maker 

The rise of the patient decision maker 

There has been a significant shift regarding treatment decision making with patients having a far stronger voice than before, informed and advocating for themselves, they are attending appointments armed with a wealth of information. Here we explore the rise of the patient decision maker.

Why medical and commercial strategy should be aligned – but not identical 

Why medical and commercial strategy should be aligned – but not identical 

When it comes to pharma’s commercial and medical teams, there’s always healthy tension – but aligning strategy is important to ensure brand success.